FDA Clearance Tracker · K191985
Optilite IgA Kit
Last checked: Nov 19, 2026Latest source record: Aug 19, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Aug 19, 2019
Substantially Equivalent
Time to decision
25 days
Received Jul 25, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K191985
- Device name
- Optilite IgA Kit
- Applicant
- The Binding Site Group , Ltd.
- Applicant location
- Edgbaston, GB
- Received
- Jul 25, 2019
- Decided
- Aug 19, 2019
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.5510
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CFN. The earliest in FDA's data is K771226, decided Jul 21, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191985
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for The Binding Site Group , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250159 · Decided Oct 17, 2025 · 269 days after receipt
Device type: Mass Spectrometric, Immunoglobulins (G, A, M, D, E) (SGG) · Laboratory Medicine & Pathology
K250549 · Decided May 23, 2025 · 87 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
K192116 · Decided Sep 4, 2019 · 29 days after receipt
Device type: Method, Nephelometric, Immunoglobulins (G, A, M) (CFN) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.